Exactmer is a life sciences technology company specialising in precision polymer synthesis for advanced therapeutics. It develops and commercialises Nanostar Sieving™, a liquid-phase synthesis and nanofiltration platform used to manufacture highly pure oligonucleotides, antibody-drug conjugate linkers and unimolecular polyethylene glycols. The company provides process development, scale-up, technology transfer, membrane supply, technology licensing and bespoke polymer production services. Its work supports pharmaceutical, biotechnology and research organisations seeking scalable, efficient and sustainable manufacturing routes for complex polymeric medicines. Exactmer operates within the pharmaceutical manufacturing, biotechnology and advanced materials sectors, with a focus on enabling next-generation therapies.